PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.86%
Revenue growth above 1.5x TSM's 0.22%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
14.93%
Gross profit growth above 1.5x TSM's 0.22%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
5.56%
EBIT growth above 1.5x TSM's 0.22%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
5.56%
Operating income growth above 1.5x TSM's 0.22%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
6.35%
Net income growth above 1.5x TSM's 0.22%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.65%
Share reduction while TSM is at 14.22%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-5.51%
Reduced diluted shares while TSM is at 14.22%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-197.06%
Negative OCF growth while TSM is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-711.11%
Negative FCF growth while TSM is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
46.78%
AR growth of 46.78% while TSM is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
-44.74%
Inventory is declining while TSM stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
6.08%
Asset growth of 6.08% while TSM is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
12.80%
BV/share growth of 12.80% while TSM is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
-34.09%
We’re deleveraging while TSM stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
22.73%
R&D growth of 22.73% while TSM is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
10.96%
SG&A growth of 10.96% while TSM is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.